Virtu Financial’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-55,746
| Closed | -$74K | – | 1495 |
|
|
2024
Q3 | $74K | Sell |
55,746
-19,333
| -26% | -$25.7K | ﹤0.01% | 952 |
|
|
2024
Q2 | $77K | Buy |
+75,079
| New | +$77K | 0.01% | 854 |
|
|
2024
Q1 | – | Sell |
-59,479
| Closed | -$74K | – | 1365 |
|
|
2023
Q4 | $74K | Buy |
+59,479
| New | +$74K | 0.01% | 1093 |
|
|
2023
Q3 | – | Sell |
-50,633
| Closed | -$46K | – | 1244 |
|
|
2023
Q2 | $46K | Sell |
50,633
-47,221
| -48% | -$42.9K | ﹤0.01% | 1147 |
|
|
2023
Q1 | $55K | Buy |
+97,854
| New | +$55K | 0.01% | 1080 |
|
|
2022
Q2 | – | Sell |
-130,949
| Closed | -$94K | – | 1533 |
|
|
2022
Q1 | $94K | Buy |
+130,949
| New | +$94K | 0.01% | 985 |
|
|
2021
Q3 | – | Sell |
-46,270
| Closed | -$175K | – | 1451 |
|
|
2021
Q2 | $175K | Sell |
46,270
-117,262
| -72% | -$444K | 0.02% | 1047 |
|
|
2021
Q1 | $554K | Buy |
+163,532
| New | +$554K | 0.04% | 471 |
|
|
2020
Q4 | – | Sell |
-82,303
| Closed | -$207K | – | 1405 |
|
|
2020
Q3 | $207K | Buy |
+82,303
| New | +$207K | 0.04% | 582 |
|
|
2019
Q4 | $123K | Buy |
19,491
+543
| +3% | +$3.43K | 0.01% | 1043 |
|
|
2019
Q3 | $74K | Buy |
+18,948
| New | +$74K | 0.01% | 1138 |
|
|
2019
Q1 | – | Sell |
-28,181
| Closed | -$156K | – | 1368 |
|
|
2018
Q4 | $156K | Buy |
+28,181
| New | +$156K | 0.01% | 1020 |
|
|
2018
Q3 | – | Sell |
-10,097
| Closed | -$101K | – | 1490 |
|
|
2018
Q2 | $101K | Sell |
10,097
-13,255
| -57% | -$133K | 0.01% | 1641 |
|
|
2018
Q1 | $223K | Buy |
23,352
+10,965
| +89% | +$105K | 0.01% | 1271 |
|
|
2017
Q4 | $184K | Buy |
12,387
+2,015
| +19% | +$29.9K | 0.01% | 1714 |
|
|
2017
Q3 | $204K | Buy |
+10,372
| New | +$204K | 0.01% | 1831 |
|